{
  "id": "NCLEXRN-NGN-00123",
  "itemType": "orderedResponse",
  "question": {
    "stem": "A 45-year-old client, admitted for major depressive disorder, is being treated with paroxetine, ondansetron, and tramadol. During the morning assessment at 0800, the nurse finds the client agitated, confused, and profusely diaphoretic. Vital signs are: T 39.8°C (103.6°F), HR 135/min, BP 170/100 mmHg, RR 28/min. The nurse notes hyperreflexia and inducible clonus in both lower extremities. The nurse suspects serotonin syndrome and receives orders from the healthcare provider. In which order should the nurse implement the actions?",
    "prompt": "Arrange the nursing actions in the correct order of priority. All actions must be used.",
    "options": [
      {
        "id": "opt_1",
        "label": "1",
        "content": "Administer PRN IV lorazepam."
      },
      {
        "id": "opt_2",
        "label": "2",
        "content": "Apply a cooling blanket and initiate temperature monitoring every 15 minutes."
      },
      {
        "id": "opt_3",
        "label": "3",
        "content": "Immediately withhold the scheduled morning dose of paroxetine."
      },
      {
        "id": "opt_4",
        "label": "4",
        "content": "Place the client on continuous cardiac and oxygen saturation monitoring."
      },
      {
        "id": "opt_5",
        "label": "5",
        "content": "Administer prescribed cyproheptadine."
      },
      {
        "id": "opt_6",
        "label": "6",
        "content": "Obtain a blood sample for creatine kinase (CK) level."
      }
    ]
  },
  "solution": {
    "correctOrder": [
      "opt_3",
      "opt_4",
      "opt_1",
      "opt_2",
      "opt_5",
      "opt_6"
    ]
  },
  "rationale": {
    "correct": "The priority order of interventions for serotonin syndrome focuses on removing the offending agent, providing immediate life support and stabilization, and then administering specific treatments and monitoring for complications. The first action is to discontinue all serotonergic agents (withholding paroxetine). Next, immediate physiological monitoring (cardiac and SpO2) is critical to detect life-threatening arrhythmias and hypoxia. Administering IV lorazepam is the third step, as it is the first-line treatment for agitation, seizure-like activity, and myoclonus, and it helps reduce hyperthermia by decreasing muscle activity. The fourth step is to apply a cooling blanket to directly manage the severe hyperthermia, a major cause of mortality. Administering cyproheptadine, a serotonin antagonist, is a subsequent action for moderate-to-severe cases once initial stabilization is underway. Finally, obtaining a CK level is important for monitoring for rhabdomyolysis but is not an immediate life-saving intervention.",
    "answerBreakdown": [
      {
        "label": "Immediately withhold the scheduled morning dose of paroxetine.",
        "content": "**Priority:** Highest. **Rationale:** Paroxetine is a selective serotonin reuptake inhibitor (SSRI) and a likely contributor to the serotonin syndrome. Serotonin syndrome is caused by excessive serotonin in the central nervous system (CNS) and peripheral nervous system. SSRIs prevent the reuptake of serotonin, leading to increased serotonin levels in the synaptic cleft. Discontinuing the medication is crucial to prevent further accumulation of serotonin and worsening of the condition. This directly addresses the underlying cause of the syndrome. **Clinical Pearl:** Never abruptly stop SSRIs without consulting a provider due to potential withdrawal symptoms (discontinuation syndrome), but in serotonin syndrome, immediate cessation is vital.",
        "order": 1
      },
      {
        "label": "Place the client on continuous cardiac and oxygen saturation monitoring.",
        "content": "**Priority:** High. **Rationale:** Serotonin syndrome can cause significant cardiovascular and respiratory complications, including tachycardia, hypertension, and hyperthermia, which increase oxygen demand. Continuous cardiac monitoring is essential to detect arrhythmias (e.g., prolonged QT interval, ventricular tachycardia) caused by excessive serotonin activity on cardiac cells. Oxygen saturation monitoring helps identify and manage respiratory compromise due to muscle rigidity or hyperthermia-induced increased metabolic demand. **Clinical Pearl:** Be vigilant for signs of respiratory distress, such as increased work of breathing or decreased oxygen saturation, and be prepared to provide respiratory support.",
        "order": 2
      },
      {
        "label": "Administer PRN IV lorazepam.",
        "content": "**Priority:** High. **Rationale:** Lorazepam, a benzodiazepine, is a first-line treatment for managing the agitation, neuromuscular hyperactivity (clonus, hyperreflexia), and potential seizures associated with serotonin syndrome. Benzodiazepines enhance the effect of GABA, an inhibitory neurotransmitter, which helps to reduce neuronal excitability and muscle rigidity. By reducing muscle activity, lorazepam also helps to lower body temperature. **Clinical Pearl:** Monitor the client closely for respiratory depression, a potential side effect of benzodiazepines, especially in the context of other medications and the client's compromised physiological state.",
        "order": 3
      },
      {
        "label": "Apply a cooling blanket and initiate temperature monitoring every 15 minutes.",
        "content": "**Priority:** High. **Rationale:** Hyperthermia is a life-threatening complication of serotonin syndrome. Elevated body temperature (39.8°C/103.6°F) can lead to rhabdomyolysis (muscle breakdown), metabolic acidosis, and multi-organ failure. Active cooling measures, such as a cooling blanket, are essential to reduce the body temperature rapidly and prevent further complications. Frequent temperature monitoring (every 15 minutes) allows for close assessment of the effectiveness of the cooling interventions and timely adjustments as needed. **Clinical Pearl:** Avoid antipyretics like acetaminophen or ibuprofen, as they are ineffective in treating hyperthermia caused by serotonin syndrome because the elevated temperature is due to increased muscle activity and not an elevated hypothalamic set point.",
        "order": 4
      },
      {
        "label": "Administer prescribed cyproheptadine.",
        "content": "**Priority:** Intermediate. **Rationale:** Cyproheptadine is a histamine-1 (H1) receptor antagonist with non-specific serotonin 5-HT1A and 5-HT2A receptor antagonist properties. It is used as an antidote in moderate to severe cases of serotonin syndrome to block the effects of excess serotonin. However, it is typically administered after initial stabilization with supportive measures like discontinuing the offending agent and administering benzodiazepines. Cyproheptadine is most effective when given early in the course of the syndrome. **Clinical Pearl:** Cyproheptadine is available in oral form, so if the patient can take oral medications, this route is preferred. If not, it can be administered via nasogastric tube.",
        "order": 5
      },
      {
        "label": "Obtain a blood sample for creatine kinase (CK) level.",
        "content": "**Priority:** Lowest. **Rationale:** While important for monitoring, checking for rhabdomyolysis (indicated by an elevated CK level) is a diagnostic/monitoring action that follows immediate, life-sustaining interventions. Rhabdomyolysis is a serious complication of serotonin syndrome caused by muscle breakdown due to hyperthermia and rigidity. Elevated CK levels indicate muscle damage and can lead to acute kidney injury. The CK level will guide further treatment, such as IV fluids for renal protection, but does not take precedence over immediate stabilization. **Clinical Pearl:** Monitor urine output and color. Dark, tea-colored urine can indicate myoglobinuria, a sign of rhabdomyolysis, requiring aggressive fluid resuscitation.",
        "order": 6
      }
    ]
  },
  "pedagogy": {
    "bloomLevel": "Applying",
    "cjmmStep": "Take Actions",
    "nclexCategory": "Pharmacological and Parenteral Therapies",
    "difficulty": 4,
    "topicTags": [
      "Serotonin Syndrome",
      "Pharmacology",
      "Prioritization",
      "Emergency Management",
      "Patient Safety"
    ]
  },
  "sbar": {
    "situation": "45-year-old client with major depressive disorder experiencing agitation, confusion, diaphoresis, hyperthermia (39.8°C), tachycardia (135 bpm), hypertension (170/100 mmHg), tachypnea (28 bpm), hyperreflexia, and inducible clonus. Suspect serotonin syndrome.",
    "background": "Client is being treated with paroxetine, ondansetron, and tramadol. Serotonin syndrome is a known risk with these medications, especially in combination.",
    "assessment": "Client exhibits signs and symptoms consistent with serotonin syndrome, including altered mental status, autonomic instability, and neuromuscular abnormalities. Vital signs are significantly elevated.",
    "recommendation": "Immediately withhold paroxetine. Initiate continuous cardiac and oxygen saturation monitoring. Administer PRN IV lorazepam for agitation and neuromuscular symptoms. Apply a cooling blanket and monitor temperature every 15 minutes. Administer prescribed cyproheptadine. Obtain a blood sample for CK level to assess for rhabdomyolysis."
  },
  "sentinelStatus": "healed_v2026_v8"
}